ID

17306

Description

Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00605111

Link

https://clinicaltrials.gov/show/NCT00605111

Keywords

  1. 9/6/16 9/6/16 -
Uploaded on

September 6, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes NCT00605111

Eligibility Diabetes NCT00605111

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00605111
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes for at least 24 months
Description

Non-Insulin-Dependent Diabetes Mellitus disease length

Data type

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
bmi between 18 and 30 kg/m2
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
insulin naive subjects
Description

Insulin Therapy naive

Data type

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0919936
oad treatment with max two oads alone or combined with other therapy
Description

Oral hypoglycemic Quantity | Combined Modality Therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0359086
UMLS CUI [1,2]
C1265611
UMLS CUI [2]
C0009429
hba1c between 7-12%
Description

Glycosylated hemoglobin A

Data type

boolean

Alias
UMLS CUI [1]
C0019018
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 diabetes
Description

Diabetes Mellitus, Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0011854
receipt of any investigational drug within the last three months prior to this trial
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
current or previous treatment with thiazolidiones within the last 6 months
Description

Thiazolidinediones

Data type

boolean

Alias
UMLS CUI [1]
C1257987
oad treatment with three or more oads within the last 4 months
Description

Oral hypoglycemic Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0359086
UMLS CUI [1,2]
C1265611

Similar models

Eligibility Diabetes NCT00605111

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00605111
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus disease length
Item
type 2 diabetes for at least 24 months
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Body mass index
Item
bmi between 18 and 30 kg/m2
boolean
C1305855 (UMLS CUI [1])
Insulin Therapy naive
Item
insulin naive subjects
boolean
C0021641 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
Oral hypoglycemic Quantity | Combined Modality Therapy
Item
oad treatment with max two oads alone or combined with other therapy
boolean
C0359086 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0009429 (UMLS CUI [2])
Glycosylated hemoglobin A
Item
hba1c between 7-12%
boolean
C0019018 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Investigational New Drugs
Item
receipt of any investigational drug within the last three months prior to this trial
boolean
C0013230 (UMLS CUI [1])
Thiazolidinediones
Item
current or previous treatment with thiazolidiones within the last 6 months
boolean
C1257987 (UMLS CUI [1])
Oral hypoglycemic Quantity
Item
oad treatment with three or more oads within the last 4 months
boolean
C0359086 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial